|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Culhane AC and Quackenbush J: Confounding
effects in ‘a six-gene signature predicting breast cancer lung
metastasis’. Cancer Res. 69:7480–7485. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Theodoropoulos GE, Saridakis V, Karantanos
T, et al: Toll-like receptors gene polymorphisms may confer
increased susceptibility to breast cancer development. Breast.
21:534–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Makri A, Pissimissis N, Lembessis P, et
al: The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer
Treat Rev. 34:682–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muir AI, Chamberlain L, Elshourbagy NA, et
al: AXOR12, a novel human G protein-coupled receptor, activated by
the peptide KiSS-1. J Biol Chem. 276:28969–28975. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kotani M, Detheux M, Vandenbogaerde A, et
al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the
natural ligands of the orphan G protein-coupled receptor GPR54. J
Biol Chem. 276:34631–34636. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang T, Zhang SL, Lin B, et al:
Expression and clinical significance of KiSS-1 and GPR54 mRNA in
endometrial carcinoma. Zhonghua Zhong Liu Za Zhi. 27:229–231.
2005.(In Chinese). PubMed/NCBI
|
|
9
|
Song GQ and Zhao Y: Different therapeutic
effects of distinct KISS1 fragments on breast cancer in vitro and
in vivo. Int J Oncol. 43:1219–1227. 2013.PubMed/NCBI
|
|
10
|
Olbrich T, Ziegler E, Türk G, et al:
Kisspeptin-10 inhibits bone-directed migration of GPR54-positive
breast cancer cells: evidence for a dose-window effect. Gynecol
Oncol. 119:571–578. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scheel C and Weinberg RA: Phenotypic
plasticity and epithelial-mesenchymal transitions in cancer and
normal stem cells? Int J Cancer. 129:2310–2314. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hong J, Zhang Z, Lv W, et al: Icaritin
synergistically enhances the radiosensitivity of 4T1 breast cancer
cells. PLoS One. 8:e713472013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zohrabian VM, Nandu H, Gulati N, et al:
Gene expression profiling of metastatic brain cancer. Oncol Rep.
18:321–328. 2007.PubMed/NCBI
|
|
15
|
Dhar DK, Naora H, Kubota H, et al:
Downregulation of KiSS-1 expression is responsible for tumor
invasion and worse prognosis in gastric carcinoma. Int J Cancer.
111:868–872. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cebrian V, Fierro M, Orenes-Piñero E, et
al: KISS1 methylation and expression as tumor stratification
biomarkers and clinical outcome prognosticators for bladder cancer
patients. Am J Pathol. 179:540–546. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hata K, Dhar DK, Watanabe Y, Nakai H and
Hoshiai H: Expression of metastin and a G-protein-coupled receptor
(AXOR12) in epithelial ovarian cancer. Eur J Cancer. 43:1452–1459.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li N, Wang HX, Zhang J, Ye YP and He GY:
KISS-1 inhibits the proliferation and invasion of gastric carcinoma
cells. World J Gastroenterol. 18:1827–1833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Navenot JM, Fujii N and Peiper SC:
Activation of Rho and Rho-associated kinase by GPR54 and KiSS1
metastasis suppressor gene product induces changes of cell
morphology and contributes to apoptosis. Mol Pharmacol.
75:1300–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roseweir AK, Katz AA and Millar RP:
Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3
beta-FAK feedback loop in HTR8SVneo cells. Placenta. 33:408–415.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramaesh T, Logie JJ, Roseweir AK, et al:
Kisspeptin-10 inhibits angiogenesis in human placental vessels ex
vivo and endothelial cells in vitro. Endocrinology. 151:5927–5934.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho SG, Yi Z, Pang X, et al:
Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor
angiogenesis by suppressing Sp-1-mediated VEGF expression and
FAK/Rho GTPase activation. Cancer Res. 69:7062–7070. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Usui S, Iso Y, Sasai M, et al:
Kisspeptin-10 induces endothelial cellular senescence and impaired
endothelial cell growth. Clin Sci. 127:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakajima S, Doi R, Toyoda E, et al:
N-cadherin expression and epithelial-mesenchymal transition in
pancreatic carcinoma. Clin Cancer Res. 10:4125–4133. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Werling AM, Doerflinger Y, Brandner JM, et
al: Homo- and heterotypic cell-cell contacts in Merkel cells and
Merkel cell carcinomas: heterogeneity and indications for cadherin
switching. Histopathology. 58:286–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
